相关实验视频

Updated: Jul 28, 2025

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

在癌症免疫疗法中,白素-15的研究进展

Menghan Cai¹, Xuan Huang^2,3, Xiting Huang^2,3

¹School of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, Macau SAR, China.

Frontiers in pharmacology

|May 30, 2023

概括

介素-15 (IL-15) 对于免疫细胞功能至关重要,并且在癌症免疫治疗中显示出有前途. 最近在IL-15激动剂开发方面的进展有效地抑制了瘤生长和转移.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

介素-15 (IL-15) 是一种细胞因子,对免疫细胞的发育和激活至关重要.
IL-15属于互白素-2 (IL-2) 家族,影响自然杀手 (NK) 细胞,T细胞和B细胞.
新兴研究强调IL-15在癌症免疫治疗中的重要作用.

研究的目的:

在过去五年中,回顾最近的互白素-15 (IL-15) 研究进展.
突出IL-15在癌症免疫治疗中的潜在应用.
总结IL-15激动分子开发的进展情况.

主要方法:

对过去五年科学出版物的文献综述.
对专注于免疫反应中的IL-15功能研究的分析.
对癌症治疗中IL-15激动分子临床试验数据的检查.

主要成果:

IL-15激动剂已经证明在抑制瘤生长方面具有有效性.
IL-15激动剂在预防癌症转移方面显示出潜在的潜力.
目前有几种IL-15激动剂疗法正在进行临床试验.

结论:

互乐金-15是一种关键的细胞因子,在癌症免疫治疗中具有巨大的潜力.
开发IL-15激动剂代表了癌症治疗的有前途的治疗策略.
持续的研究和临床试验对于充分实现IL-15在瘤学中的好处至关重要.

关键词:

癌症癌症癌症癌症癌症癌症免疫疗法免疫疗法细胞因子细胞因子互乐金-15激动剂的激动剂再组合的融合蛋白质.

更多相关视频

Analysis of Human Natural Killer Cell Metabolism

Analysis of Human Natural Killer Cell Metabolism

Published on: June 22, 2020

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...